A multicenter retrospective study of patients with pulmonary hypertension transitioned from inhaled to oral treprostinil

Oral treprostinil has recently been shown to delay disease progression in patients with pulmonary arterial hypertension in a long-term outcomes study. The potential advantages of an oral formulation have resulted in patients transitioning from inhaled to oral treprostinil. The current study reports...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwicke, Diane L., Restrepo-Jaramillo, Ricardo, Alnuaimat, Hassan, Gordon, Kathryn, Broderick, Meredith, Edwards, Lisa D., Allmon, Andrew, Leary, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934059/
https://www.ncbi.nlm.nih.gov/pubmed/33738096
http://dx.doi.org/10.1177/2045894021998203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934059/
https://www.ncbi.nlm.nih.gov/pubmed/33738096
http://dx.doi.org/10.1177/2045894021998203

Ejemplares similares